文献速递垂体与肾上腺疾病

无泌乳素瘤成人血清泌乳素水平与死亡率:一项Meta分析

Serum Prolactin Levels and Mortality in Adults Without Prolactinoma: A Meta-Analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本系统综述与Meta分析纳入截至2023年6月10日的文献,评估无泌乳素瘤成人血清泌乳素(PRL)水平与死亡风险的关联。PRL水平与院内死亡的关联未达统计学显著。作者结论认为PRL水平似乎是死亡的独立预测因素,但在临床实践中将其用作风险分层工具前需进一步验证。

要点

  • PRL水平与院内死亡的关联未达统计学显著。

核心结论

  • PRL水平似乎是死亡的独立预测因素,但在临床实践中将其用作风险分层工具前需进一步验证。

研究设计与样本

  • 系统综述与随机效应Meta分析,文献检索截至2023年6月10日,纳入报告无泌乳素瘤成人血清PRL水平与临床结局关联的研究。
  • 28项研究符合纳入标准,其中14项研究报告了适合Meta分析的数据,共纳入23 596人。

主要发现

  • PRL水平与院内死亡的关联未达统计学显著。

局限性

  • PRL水平与院内死亡的关联未达统计学显著。
  • 全因死亡分析异质性I²=48%,心血管死亡分析异质性I²=89%,最高PRL类别全因死亡分析异质性I²=65%,最高PRL类别心血管死亡分析异质性I²=82%。
  • 作者结论指出,在临床实践中将PRL用作风险分层工具前需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Prolactin (PRL) is a highly versatile, multifunctional hormone synthesized and secreted by lactotroph cells of the anterior pituitary. Its metabolic role has been extensively studied even in normoprolactinemic populations. Recently, a wealth of observational data have outlined the potential prognostic value of PRL in various clinical settings. OBJECTIVE: This systematic review aims to systematically evaluate and quantitatively synthesize the association between serum PRL levels and risk of mortality in adults without prolactinoma. METHODS: A systematic literature search was conducted up to June 10, 2023, to identify studies reporting the association of serum PRL levels with clinical outcomes of adults without prolactinoma. A random-effects meta-analysis was conducted to quantify the adjusted hazard ratios [(a)HRs] for all-cause and cardiovascular death (CVD) during follow-up. RESULTS: Twenty-eight studies were deemed eligible reporting the outcomes of adults without prolactinoma, in whom serum PRL levels were measured for risk-stratification. Fourteen studies reported appropriate data for meta-analysis encompassing a total of 23 596 individuals. Each unit of PRL increase was independently associated with increased risk of all-cause (pooled aHR = 1.17 [1.08-1.27]; I2 = 48%) and CV mortality (pooled aHR = 1.54 [1.14-2.09]; I2 = 89%). Individuals belonging to the highest PRL category had significantly higher risk for all-cause (pooled aHR = 1.81 [1.43-2.30]; I2 = 65%) and CV (pooled aHR = 1.59 [1.04-2.42]; I2 = 82%) mortality compared to their lowest-PRL category counterparts. The association between PRL levels and in-hospital death did not reach statistical significance. CONCLUSION: PRL levels seem to be an independent predictor for mortality. Further validation is warranted before its role as a risk-stratification tool can be delineated in clinical practice.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Papazoglou AS, Leite AR, Moysidis DV, et al. Serum Prolactin Levels and Mortality in Adults Without Prolactinoma: A Meta-Analysis. J Clin Endocrinol Metab. 2024. PMID: 38366650. doi:10.1210/clinem/dgae087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。